Research
Hormonal
GLP-1 receptor agonists show promising results in men, improving erectile function, testosterone levels, and sperm parameters.
Practitioners may consider GLP-1 receptor agonists as a potential treatment option for men experiencing erectile dysfunction.
StrongSupportsmedium confidence
GLP-1 receptor agonists show promising results in men, improving erectile function, testosterone levels, and sperm parameters.
Why this rating
The claim is based on a comprehensive narrative review of recent evidence.
Source
Beyond metabolism: sexual dysfunction and weight-loss drugs
Jenyfer M Fuentes-Mendoza et al. · Sexual Medicine Reviews · 2025
DOI 10.1093/sxmrev/qeaf074
reviewCited 1×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →